StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.27+0.12 (+1.47%)

Close on Nov 18, 2026Market cap $288.48MP/E –Yield –

Benitec Biopharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Benitec Biopharma

Benitec Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Benitec Biopharma figures

See a number that looks wrong?